Free Trial

Cognex Corporation (NASDAQ:CGNX) Given Consensus Rating of "Moderate Buy" by Analysts

Cognex logo with Computer and Technology background

Key Points

  • Cognex Corporation has received a consensus rating of "Moderate Buy" by 15 research firms, with an average target price of $42.31.
  • The company reported earnings per share of $0.25 for the last quarter, surpassing analysts' expectations of $0.23, and its revenue was $249.09 million, exceeding predictions.
  • Cognex has announced a quarterly dividend of $0.08, with an annual yield of 0.7%, payable to investors of record on August 14th.
  • Need better tools to track Cognex? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Shares of Cognex Corporation (NASDAQ:CGNX - Get Free Report) have earned a consensus rating of "Moderate Buy" from the fifteen research firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, seven have given a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $42.3077.

Several equities research analysts have recently weighed in on the stock. KeyCorp upgraded shares of Cognex from a "sector weight" rating to an "overweight" rating and set a $50.00 price objective for the company in a research report on Friday, August 1st. TD Cowen raised Cognex from a "hold" rating to a "buy" rating and set a $35.00 target price on the stock in a research report on Monday, April 28th. The Goldman Sachs Group raised their price target on shares of Cognex from $29.00 to $32.00 and gave the company a "sell" rating in a research report on Thursday, June 12th. Citigroup reaffirmed a "neutral" rating and set a $37.00 price objective (up from $30.00) on shares of Cognex in a report on Monday, July 14th. Finally, UBS Group boosted their target price on Cognex from $53.00 to $58.00 and gave the stock a "buy" rating in a research note on Friday, August 1st.

View Our Latest Analysis on CGNX

Cognex Trading Up 0.1%

NASDAQ CGNX opened at $42.74 on Friday. Cognex has a 1 year low of $22.67 and a 1 year high of $44.38. The firm's 50 day simple moving average is $35.56 and its 200 day simple moving average is $32.09. The firm has a market capitalization of $7.18 billion, a price-to-earnings ratio of 60.20 and a beta of 1.47.

Cognex (NASDAQ:CGNX - Get Free Report) last released its quarterly earnings data on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.23 by $0.02. The business had revenue of $249.09 million during the quarter, compared to analysts' expectations of $246.70 million. Cognex had a net margin of 13.13% and a return on equity of 6.65%. The firm's quarterly revenue was up 4.2% compared to the same quarter last year. During the same period in the prior year, the company earned $0.23 EPS. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. On average, equities research analysts forecast that Cognex will post 0.61 earnings per share for the current year.

Cognex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, August 28th. Investors of record on Thursday, August 14th will be issued a $0.08 dividend. The ex-dividend date of this dividend is Thursday, August 14th. This represents a $0.32 annualized dividend and a yield of 0.7%. Cognex's dividend payout ratio (DPR) is 45.07%.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Nordea Investment Management AB increased its holdings in shares of Cognex by 148.5% in the second quarter. Nordea Investment Management AB now owns 7,075,772 shares of the scientific and technical instruments company's stock worth $223,594,000 after buying an additional 4,228,729 shares during the period. Mackenzie Financial Corp lifted its stake in Cognex by 126.2% in the first quarter. Mackenzie Financial Corp now owns 4,609,802 shares of the scientific and technical instruments company's stock worth $137,510,000 after acquiring an additional 2,571,457 shares during the period. AQR Capital Management LLC lifted its position in shares of Cognex by 18,810.9% in the 2nd quarter. AQR Capital Management LLC now owns 1,794,649 shares of the scientific and technical instruments company's stock worth $56,657,000 after purchasing an additional 1,785,159 shares during the period. T. Rowe Price Investment Management Inc. boosted its position in Cognex by 32.0% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 6,082,319 shares of the scientific and technical instruments company's stock valued at $181,436,000 after acquiring an additional 1,474,832 shares in the last quarter. Finally, Mawer Investment Management Ltd. bought a new stake in shares of Cognex during the second quarter valued at approximately $45,723,000. Institutional investors own 88.12% of the company's stock.

Cognex Company Profile

(Get Free Report)

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.

Further Reading

Analyst Recommendations for Cognex (NASDAQ:CGNX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cognex Right Now?

Before you consider Cognex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cognex wasn't on the list.

While Cognex currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines